Breast cancer patients were further divided into three different groups according to their separate proliferation potential (Figure 4(a)), and the expression level of NPPA was gradually decreased in patients with higher proliferation potential (Figure 4(b)). The gene discussed is NPPA; the disease is breast cancer.